(2026). Significant Response to Nivolumab Plus Ipilimumab in Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report. IJU Case Reports.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Significant Response to Nivolumab Plus Ipilimumab in Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report."
IJU Case Reports 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Significant Response to Nivolumab Plus Ipilimumab in Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report."
IJU Case Reports, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.